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Abstract 37 
Purpose:  38 
Anorexia nervosa (AN) is a serious, poorly understood, and often chronic condition. 39 
Deviations in the gut microbiota have been reported to influence the gut-brain axis in 40 
other disorders. Therefore, if present in AN, it may impact on symptoms and illness 41 
progression. A review of the gut microbiota studies in AN is presented.  42 
  43 
Method:  44 
A literature search on PubMed yielded 27 articles; 14 were selected and based on 45 
relevance, 9 articles were included in the review. The findings were interpreted in 46 
the larger context of preclinical research and clinical observations.  47 
 48 
Results:  49 
8 out of 9 included studies analysed microbiota from faeces samples, while the last 50 
analysed a protein in plasma produced by the gut. Two studies were longitudinal 51 
and included an intervention (i.e., weight restoration), five were cross-sectional, one 52 
was a case report, and the last was a case series consisting of three cases. 53 
Deviations in abundance, diversity, and microbial composition of the faecal 54 
microbiota in AN were found.  55 
 56 
Conclusion:  57 
There are currently only a few studies on the gut microbiota in AN, all done on 58 
faeces samples, and not all describe the microbiota at the species level extensively. 59 
In four studies the Archaeon M.smithii was found increased in AN and may be an 60 
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interesting benchmark biomarker for future studies. It is furthermore proposed that 61 
microbiota samples could also be collected from the small intestine, where a major 62 
exchange of nutrients takes place and where the microbiota may have a relevant 63 
biological impact on AN. 64 
 65 
Key words: Anorexia Nervosa, faeces, microbiota, species, biomarker. 66 
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Introduction  69 
Anorexia nervosa (AN) is a serious and often chronic psychiatric condition [1]. The 70 
hallmark feature of AN is a reduction of energy intake relative to energy expenditure 71 
leading to low body weight. Potential life-threatening medical complications that 72 
affect almost every organ frequently occur contributing to AN having a high 73 
standardized mortality ratio of 5.2 [3.7-7.5] [2]. In addition, there are no effective 74 
treatments for AN and chronicity is high [3]. 75 
 76 
Elucidating biomarkers associated with AN could provide guidance for risk 77 
stratification, treatment and identify targets for developing novel pharmacological 78 
treatments as well as increasing disease understanding. Studies have begun to 79 
explore whether the gut microbiota and its associated microbiome might harbor trait 80 
biomarkers for AN.  81 
Definitionally, “microbiota” refers to a community of microorganisms, including 82 
Bacteria, Viruses, Archaea, and Fungi, and in this review, we have focused on the 83 
gut Bacteria and Archaea in AN. The “microbiome” refers to the collective genomes 84 
of the present microorganisms [4]. More than 1,000 ‘species-level’ phylotypes exist 85 
in a human [5]. The majority of these phylotypes are Bacteria, with Faecalibacterium 86 
prausnitzii, Roseburia intestinalis, and Bacteroides uniformis dominating in the adult 87 
microbiota found in faeces samples [6]. The phylotypes are mostly consistent across 88 
individuals, but the relative composition and diversity of organisms can vary 89 
markedly. In addition, diet has been shown to influence intestinal dysbiosis 90 
influencing both risk of glucose intolerance and cancer development [7,8].  91 
 92 
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Gut microbiota not only play a critical role in the development of the gut mucosal 93 
immunity [9,10], but also affect the regulation of the hypothalamic-pituitary-adrenal 94 
(HPA) axis [11], serotonergic neurotransmission [12], and signaling mechanisms 95 
affecting neuronal circuits involved in motor control and anxiety in mice [13]. This 96 
pathway has been described as the gut-brain axis [14]. The mechanism of this 97 
interaction is not fully elucidated, and there are as yet no dedicated studies to 98 
explore or intervene with this gut-brain axis in AN.  99 
 100 
Given the long periods of starvation associated with the core psychopathology of 101 
AN, considerable adaptation in intestinal microbiota could occur in people with AN. 102 
Alternatively, specific intestinal dysbiosis could predispose to the drive toward 103 
negative energy balance in AN. Intestinal dysbiosis is known to have an impact on 104 
psychological function and mental health including depression and anxiety, both of 105 
which are commonly comorbid with AN [15]. AN patients often present with 106 
comorbid anxiety (75% lifetime prevalence of anxiety disorder) [16] and more than 107 
34% prevalence of depression [17,18]. As such, the gut-brain axis is of particular 108 
interest in understanding the psychopathology of AN.   109 
 110 
The intestinal microbiota is involved in both weight gain and weight loss as well as 111 
with energy extraction from the diet in both humans and animals [19,20]. Differences 112 
in the composition of the intestinal microbiota between obese and lean individuals 113 
have been consistently described, potentially illustrating differences in energy 114 
extraction efficiency between obese and lean individuals [21,22]. Furthermore, in an 115 
activity based mouse model of AN Jésus et al. demonstrated increased permeability 116 
in the colon, i.e. “gut leakiness”, in anorexic mice, however the authors also found 117 
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that the gut leakiness was more related to malnutrition than exercise[23]. In another 118 
study examining the role of exercise on gut permeability, Pals et al. found that 119 
exercise increases intestinal permeability measured with the lactulose and 120 
rhamnose differential urinary excretion test [24]. In contrast to this, a study by 121 
Monteleone et al. found reduced urinary recovery of lactulose in AN patients 122 
reflecting a reduced permeability in the small intestine, where breakdown and 123 
absorption of lactulose take place [25].  124 
Changes in the intestinal permeability may be caused by AN pathophysiology, 125 
however, the current results on gut permeability in AN are conflicting. The potential 126 
altered gut permeability in AN may underlie the low-grade inflammation and 127 
increased risk of autoimmune diseases found in eating disorders [26]. Moreover, 128 
starvation has a significant impact on the gut microbiota, and a diet based on animal 129 
products used for re-nutrition, may stimulate the growth of Bacteria that triggers 130 
inflammation [27]. 131 
The small intestine, notably the ileum, contains a microbial flora and the major 132 
breakdown of food and metabolism take place there making the small intestine an 133 
area of interest in AN, where restrive dietary intake is characteristic of the eating 134 
disorder. This region is driven by rapid uptake, fast transit times, excretions of 135 
digestive enzymes and bile salts, which collectively put a selective driving force on 136 
resilient microbes with effective survival strategies that differ from those found in the 137 
colon [28]. The microbiota found in ileal effluent, which has a uniquely personal 138 
composition [29], differ from that found in faeces samples with lower overall 139 
diversity, fast changing profiles, and increased relative abundances of species 140 
within the orders Lactobacillales and Clostridiales, and below detection limits of 141 
Archaea [30-32]. In addition, studies have shown that the microbiota is highly 142 
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specific for different gut compartments and even differs within compartments, i.e. 143 
the colon [29,33-35].  144 
 145 
The aim of this article is to conduct a review of the evidence of differences in the 146 
faecal microbiota in AN compared to healthy controls. This could provide clues to 147 
the pathophysiology of AN, index biomarkers, and generate new ideas for treatment 148 
development. In addition, guidance for future research is provided. 149 
 150 
Method  151 
Protocol for the review 152 
The protocol is available as a table online at this URL: 153 
https://drive.google.com/open?id=0B1bvPK36OlXANVZGNXduSU85RWs  154 
Eligibility criteria 155 
In view of the rather few studies done, all articles were included, except reviews, 156 
animal studies, and studies with no relevance to the intestinal microbiota in AN and 157 
the gut-brain axis (Figure 1).   158 
Data sources  159 
The PubMed database in the US National Library of Medicine was searched to 160 
identify any relevant studies on August 27, 2017.  161 
 162 
Search Strategy 163 
The following search terms were included: “Anorexia nervosa” and “microbiota”. The 164 
reference lists of studies were also handchecked for additional articles of interest. 165 
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 166 
Study selection 167 
We only included original scientific publications, where the human microbiota were 168 
analysed in persons with AN. Excluded were review articles, commentaries, 169 
preclinical and animal studies and all other types of non-scientific original 170 
publications. One case study was also excluded as it examined fungi from a faeces 171 
sample instead of Bacteria and Archaea, of which the two latter are the focus point 172 
of this review (Figure 1).  173 
 174 
Data collection process 175 
Given the heterogeneity in methods and the limited number of publications, results 176 
were evaluated as presented in the source publications (Table 1). No additional 177 
analysis were made to the original presentations of data and the corresponding 178 
results. 179 
 180 
Risk of Bias 181 
Risk of bias was assessed by HFS and JMS by reviewing the study designs, the 182 
methods used, any selection mechanisms presented, and the consistency of results 183 
presentation. Risk of bias is included in the above linked protocol. 184 
 185 
Synthesis of results 186 
The full texts were then retrived and read in full by two authors (HFS and JMS) 187 
independently to determine whether the studies met inclusion criteria, and HFS 188 
wrote the manuscript with extensive help from the fifth author (JMS). A second 189 
author (CK) and a third author (JT) provided important revisions on science and 190 
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content to the manuscript, and a fourth author (NH) provided expert input on the 191 
microbiota and its role in the metabolism and absorption of nutrients, and a critical 192 
view on the limitations of the few studies done so far. As raw data were not 193 
extracted, there was no handling of data or combining of results.  194 
 195 
Results  196 
The search terms “anorexia nervosa” and “microbiota” yielded a total of 27 unique 197 
articles. Reviewing the reference lists of all articles did not yield any additional 198 
original scientific publications relevant for this review. All 27 articles were screened 199 
and assessed for eligibility. 18 of these articles did not meet the eligibility criteria 200 
and were excluded (Figure 1). The main study characteristics of the 9 included 201 
studies are summarized in Table 1. During revision of this article for publication 202 
another study by Mörkl et al. published in November 2017 was included in this 203 
article and in Table 1 [36], and thus a total of 10 articles were included. See the end 204 
of the “Results” paragraph for a review of the findings by Mörkl et al. 205 
Of the 10 studies included in this review, two were longitudinal in design [37,38], six 206 
were cross-sectional [39-43,36], one was a case study involving a severe case of 207 
AN [44], and the last study was a case series consisting of three cases that was 208 
also longitunal in its design [45]. The diagnostic criteria used for AN were from 209 
Diagnostic and Statistical Manual IV (DSM-IV) in four studies [39,37,40,41], from 210 
DSM-5th Edition in two studies [45,42], from ICD-10 in one study [36], and not 211 
specified in three studies [44,43,38]. All studies except one were published in the 212 
last five years [39].  213 
The number of AN patients included in the six cross-sectional studies ranged 214 
between 9 and 25 [39-43,36], and between 16 and 55 in the two longitudinal studies  215 
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[37,38]. Three patients with AN were included in the case series [45]. In the 216 
longitudinal studies over the course of renourishment, the second time point (T2) 217 
was defined as after approximately 14 weeks in one of the studies [38], and when a 218 
mean Body Mass Index (BMI) goal of approximately 17.4 kg/m2 was achieved in the 219 
other study [37]. Healthy controls were included in all studies, and in four of the ten 220 
studies, the controls were matched to the AN groups both for age and sex 221 
[38,41,42,36]. The 9 studies that examined the intestinal microbiota all examined it 222 
from faeces samples. 223 
The methods used for assessing quantity and type of species in faeces samples 224 
were 16S Revers Transcriptase-PCR based. Morita et al. also included 23S rRNA 225 
gene targeted technology. Two studies did not specify whether 16S or 23S rRNA 226 
gene targeted PCR was used [40,39]. Additional measures included organic acids 227 
including short-chain fatty acids and pH of faeces (chromatography) [38,41], and 228 
culture growth and mass spectrometry (Matrix-Assisted Laser Desorption-Ionization) 229 
[44], and several measures of body fat including anthropometric assessments and 230 
ultrasound measurement of subcutaneous adipose tissue thickness [36]. Three 231 
studies evaluated the relation between psychiatric measures and changes in 232 
abundance and composition of the microbiota [37,42,36], and one study examined 233 
the relation between Caseinolytic peptidase B (ClpB) protein concentrations in 234 
plasma and scores on the Eating Disorder Inventory-2 (EDI-2) and the Montgomery-235 
Åsberg Depression Rating Scale (MADRS) [43].  236 
Three studies used employees, relatives and family members of the employees as 237 
controls [39,42,38]. The other studies recruited controls through public 238 
advertisements [43,37,36], through previous studies using a snowball approach and 239 
from healthy outpatients [40], or recruited controls through non-disclosed methods 240 
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[41]. Two studies did not include controls, as the study designs were case studies 241 
[45,44]. 242 
Bias was assessed in all studies, and the results are shown in the linked online 243 
protocol. Furthermore, see Table 1 for at description of the quality of technologies 244 
used for collection and handling of faeces samples in the different studies.  245 
 246 
Microbiota results 247 
Four studies explored the abundance of gut microbiota in AN, and all investigated 248 
AN in the acute stage. Two of these studies described a normal abundance of 249 
microbiota in AN [40,38], while one found a reduced microbiota abundance in AN 250 
[41] and another an altered abundance measured on several microbial phyla, 251 
genera, and species [42]. 252 
Three studies examined the diversity in AN compared to healthy controls. Mack et 253 
al. found an overall normal microbial diversity in AN in their weight restoration study 254 
at both time point 1 (T1) and time point 2 (T2) [38], and in line with this, Borgo et al. 255 
found no significant changes in diversity in acutely ill AN patients compared to 256 
controls [42]. The other weight restoration study by Kleiman et al. found a lower 257 
alpha (within-sample) diversity at both T1 and T2 compared to controls indicating 258 
the number of observed species in the analysed faeces sample [37]. Moreover, 259 
Kleiman et al. found a significant association between alpha diversity and 260 
depression and eating disorder psychopathology [37]. Changes from T1 to T2 in 261 
persons with AN, i.e. beta diversity (between-sample diversity), was also reported 262 
by Kleiman et al., however, the alpha diversity remained significantly lower after 263 
weight gain than the observed diversity in controls [37]. In the case series, which 264 
followed three female patients with acute AN through hospitalization and weight 265 
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restoration, significant changes in magnitude of composition and diversity on phylum 266 
to genus levels were observed, however, these changes were found to be patient 267 
specific and not common changes in the three patients [45]. They also measured 268 
the resting energy expenditure (REE) and diet-induced thermogenesis in the three 269 
patients, which both increased during weight gain, but was not significantly 270 
associated with diversity or composition of the gut microbiota. 271 
Common findings in the acute stages of AN with regard to specific microbiota were 272 
that the phylum Bacteroidetes was low in AN in two studies [37,38]. Conversely, two 273 
other studies showed that Bacteriodetes also was decreased (or trending towards 274 
decreased) in obese individuals [40,39]. The phylum Firmicutes was increased in 275 
AN in three studies [39,37,38] and decreased in one study [42]. 276 
The genus Methanobrevibacter and specifically, on the species level, M. smithii was 277 
increased, when present, in AN patients compared to normal-weight participants in 278 
three studies [40,39,38]. Mack et al. detected species belonging to the genus 279 
Methanobrevibacter, of which M. smithii is the most common species in the human 280 
gut, in 22 % of patients with AN at T1, which was higher than the proportion of AN 281 
patients with Methanobrevibacter at T2 (14 %), and Methanobrevibacter was found 282 
in 15 % of controls [38]. The relative abundance of Methanobrevibacter was 283 
statistically higher in the 22 % of AN patients at T1 than the 15 % of controls 284 
(p=0.004). In the study by Million et al. M. smithii was detected in 64 % of all 285 
participants including AN patients, normal-weight controls, and obese participants 286 
(BMI>25), and M. smithii concentrations were higher in participants with BMI<25 287 
(p=0.008) with a trend towards a correlation between a higher BMI and lower M. 288 
smithii concentration (p=0.08). In line with this, Armougom et al. detected M. smithii 289 
in 100 % of the AN patients and 75 % of lean participants and found M. smithii 290 
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statistically increased in AN compared to the lean participants (p=0.0171) [39], and 291 
Borgo et al. found a significantly higher average of genome copy number of M. 292 
smithii in their AN group compared to controls [42].  293 
The case study examined the microbial composition of a faeces sample from a 21-294 
year-old Caucasian woman with a severe case of AN with a BMI of 10.4 kg/m2[44]. 295 
19 new microbial species never previously observed were found, of which 11 were 296 
isolated and sequenced. Of these, 7 species belonged to the phylum Firmicutes, 2 297 
belonged to the phylum Bacteroidetes, and 2 belonged to the phylum 298 
Actinobacteria. Interestingly, M. smithii was not identified in the faeces of the patient 299 
in contrast to the other studies that found an increase in this species in the acute 300 
stages of AN [39,40,38,42].  301 
Apart from that, no clear patterns were detectable with regard to microbiota in the 302 
nine selected studies. 303 
 304 
Effects of weight restoration 305 
Diversity and richness was initially normal and increased after weight gain in one 306 
study [38]. Kleiman et al., reported a lower diversity both at baseline and after 307 
inpatient weight restoration [37]. Duration of inpatient stay was defined in one study 308 
[38] as 14.0±6.8 weeks (mean±SD) with BMI at admission of 15.3±1.4 and at the 309 
end of treatment 17.7±1.4 (mean±SD). In the other study [37] duration of stay was 4 310 
weeks (Dr. Ian Carroll, personal communication) and BMI at admission was 311 
16.2±1.5 and 17.4±0.9 (mean±SD) at endpoint. In the case series duration of stay 312 
varied from 34 to 73 days and, as mentioned before, changes in diversity and 313 
composition were largely patient specific and no common trend was observed [45].  314 
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With regard to specific microbiota, the relative concentration of Bacteroidetes was 315 
found low at T1 and further decreased at T2 in AN compared to healthy controls in 316 
one study [38]. M.smithii and the mucin degrading genera Verrumcomicrobia and 317 
Bifidobacteria were found to be increased in AN at baseline (T1) compared to 318 
controls in one study [38], and the study by Kleiman et al., also found lower 319 
abundances of Bacteriodetes in AN after weight restoration compared to controls 320 
[37].  Firmicutes was increased compared to controls after weight restoration in both 321 
weight restoration studies in AN [38,37].  322 
 323 
Relation to clinical symptoms 324 
One weight restoration study found an improvement in total gastrointestinal (GI) 325 
scores (reflecting complaints) after weight restoration, although most upper and a 326 
few lower GI symptoms such as abdominal pain and bowel noises did not change 327 
[38], and no correlations between GI symptoms and microbiota measures where 328 
found. The other weight restoration study found an association between alpha 329 
diversity in AN and levels of depression, anxiety, and eating disorder 330 
psychopathology at baseline [37].  331 
With regards to correlations between psychiatric symptoms measured on the BDI 332 
scale and specific microbiota, Borgo et al. found a negative correlation between 333 
Clostridium spp. and depression score, and, in addition, a negative correlation 334 
between faecal butyrate concentration and depression and anxiety scores [42]. 335 
Breton et al. examined the role of ClpB protein concentrations in plasma and its 336 
correlations to clinical symptoms in 24 patients with restrictive AN, 29 patients with 337 
bulimia nervosa, 13 patients with binge-eating disorder, and 29 gender-matched 338 
controls [43]. ClpB protein is produced by Enterobacteriae such as Escheria coli and 339 
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has been found as a conformational mimetic of alfa-Melanocyte Stimulating 340 
Hormone (alfa-MSH), which is thought to be involved in satiety and anxiety [46]. 341 
Indeed, Breton et al. found that ClpB protein concentrations correlated positively 342 
with alfa-MSH-reactive IgG for all patients with eating disorders and an increase in 343 
ClpB protein concentrations was found in plasma in eating disorder patients 344 
compared to plasma in controls, and that ClpB protein concentrations were 345 
significantly correlated with several subscales on the Eating Disorder Inventory-2 346 
(EDI-2) for all patients with eating disorders and the Montgomery-Åsberg 347 
Depression Rating Scale (MADRS) total score and specifically the anhedonia score 348 
for AN patients (p<0.05). The study adds evidence to the potential role of ClpB 349 
protein produced by Enterobacteriae in the gut and its impact on the brain and 350 
psychopathology in eating disorders.   351 
 352 
Mörkl et al. examined the faecal microbiota from five groups; 18 inpatients with AN, 353 
20 athletes, 22 overweight participants, 20 obese participants, and 26 normal-weight 354 
controls [36]. They found a lower alpha diversity in AN and obese participants 355 
compared to other groups, and that the athletes had the highest alpha diversity. In 356 
addition, they found that greater levels of depression measured on the BDI 357 
correlated with a lower alpha diversity, when all groups were included in the analysis 358 
(p=0.032). Beta diversity was associated with several parameters, and beta diversity 359 
was significantly associated with several different measures of body fat (p<0.05), 360 
smoking status (p=0.002), and cholesterol-HDL ratio (p=0.024).  361 
The phylotype Coriobacteriaceae was the only enriched phylotype in AN compared 362 
to other entities. Collectively, the authors concluded that their results were evident of 363 
a gut dysbiosis in AN.  364 
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 365 
Discussion 366 
Individuals with AN are known to have a highly variable weight gain during 367 
therapeutic renourishment, and the factors that contribute to this variability are 368 
currently unclear [47]. Factors such as increased (and secretive) physical activity 369 
[48] and diet-induced thermogenesis have been proposed [49]. Thereby, it is 370 
reasonable to hypothesize that AN patients may have a microbial imbalance in their 371 
gut that in part contributes to the poor response to weight gain observed during 372 
treatment. 373 
 374 
Overall, there are few studies investigating the microbiota in AN, all are 375 
experimental, and they differ with regard to design and results. In this review, we 376 
have attempted to identify both common and divergent features in order to inform 377 
future investigations. 378 
Regarding abundance of microbiota, two studies found a normal abundance of 379 
microbiota in AN [40,38], while two studies found a reduced and altered abundance 380 
of microbiota [41,42]. The diverging results make an interpretation difficult.  381 
In four studies, the diversity of the microbiota was compared to controls and 382 
explicitly described. Two of these studies found a normal microbial diversity in AN 383 
and in the weight restoration study by Mack et al. diversity further increased after 384 
weight gain [38,42]. The third study found a lower alpha diversity compared to 385 
healthy controls that was still significantly lower upon weight gain [37], and Mörkl et 386 
al. also found a low alpha diversity in AN patients and in obese individuals. There 387 
was, however, a major difference between the two weight restoration studies in the 388 
duration of follow-up, differing by approximately 10 weeks. This may have had an 389 
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impact on the ability of the mictobiota to adjust to environmental factors. However, 390 
with only these four studies, it is too early to draw any firm conclusion on the 391 
diversity of the microbiota in AN. 392 
 393 
With regard to specific changes in microbiota species, there were some findings that 394 
may indicate the trend of change in AN. The phylum Firmicutes was found 395 
increased in AN in three studies [39,37,38], and Bacteroidetes was low in AN in two 396 
studies [37,38], although potentially conflicting findings were made in two other 397 
studies, where Bacteriodetes was found to be decreased (or trending towards 398 
decreased) in obese individuals [40,39] and Firmicutes was found to be decreased 399 
in one study [42]. Another study found an increase in the phylum Coriobacteriaceae 400 
[36]. However, these findings may also reflect that it is dysregulation per se, which 401 
may be at a similar level and direction in AN and obese individuals, and not specific 402 
BMI scores, that is related to the composition of the microbiota. Interestingly, the 403 
genus Methanobrevibacter, specifically M.smithii, was also increased, or trending 404 
towards an increase when present in patients with AN or participants with BMI<25 in 405 
four studies [40,39,38,42].  406 
M. smithii is involved in the breakdown of polysaccharides from vegetable sources 407 
and the finding of this specific Archaeon could illustrate an adaptation to a typical 408 
diet rich in vegetables and fruits in persons with AN. However, methanogenic 409 
Archaea, such as M. smithii, have also been linked to constipation, a common 410 
complaint in patients with AN, which statins have been shown to alleviate by 411 
suppressing the growth of methanogens [39,50-52]. The evidence of M. smithii in 412 
faeces from constipated patients necessitate further investigation of whether this 413 
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finding in AN patients is only related to constipation or also related to AN 414 
psychopathology as a potential biomarker. 415 
There were additional changes found in the different studies, but no clear additional 416 
patterns were detectable with regard to specific microbiota in the nine selected 417 
studies. 5 out of the 9 studies that examined the microbiota in faeces samples 418 
reported microbial changes on the species level extensively, while the remaining 419 
four studies reported mainly findings on phylum to genus level, which may be too 420 
broad [38,45,37,36]. Differences in microbial species may better reflect changes that 421 
are related to specific biological effects [53].  422 
 423 
With regard to the effect of weight gain on specific microbiota, Firmicutes was 424 
increased after weight restoration in both studies in AN [38,37]. Furthermore, the 425 
Bacteroidetes was found low before weight gain and decreasing in AN in one of the 426 
studies [38], while the other found a decreasing level of Bacteriodetes after weight 427 
restoration [37]. Only in one of the weight restoration studies were M.smithii and the 428 
mucin degraders Verrumcomicrobia and Bifidobacteria increased before weight 429 
gain, a finding that was not replicated after weight gain in AN [38]. The only 430 
significant finding after weight gain, as interpreted from the two studies, was an 431 
increase in the phylum Firmicutes. To conclude on specific microbiota differences in 432 
the acute stages of AN compared to controls, only one finding on the species level 433 
remains substantial and concrete; an increased concentration of the Archaeon 434 
M.smithii. However, on the phylum level Firmicutes was consistently shown to be 435 
overrepresented and specific species results from this phylum could be expected in 436 
the future. 437 
 438 
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9 of 10 studies included in this review collected faeces samples i.e. reflecting mainly 439 
the colorectal microbiota. Differences in the microbiota in the distal parts of the gut, 440 
when taken from faeces samples, may not relate in a meaningful way to all relevant 441 
biological functions, since faeces mainly contains a mixture of Bacteria from the 442 
various compartments of the colon and some Bacteria from the distal ileum, and 443 
therefore faeces samples are proxies for the gut microbiome rather than displaying 444 
true host-microbe interactions [54]. In the large intestine resorption of fluid and the 445 
forming of faeces take place and Bacteria are kept at a distance from the epithelial 446 
cells by the mucus coat [55,56]. Theoretically, another interesting location for 447 
microbiota sampling in AN, in addition to faeces samples, would be the small 448 
intestine, notably the ileum, where there is a microbial flora and where the major 449 
breakdown of food and absorption of nutrients take place. Furthermore, Bacteria 450 
and Archaea from the small intestine are subjected to a harsh environment with fast 451 
transit time, digestive enzymes, and bile, and therefore largely contrast the 452 
environment in the colon, demanding more resilient inhabitants in the small intestine 453 
with different survival strategies, and these microbes are also subjected to 454 
breakdown through the digestive tract [28]. Any reported findings in faeces might 455 
therefore not represent the microbiota in the small intestine. A study by Vandeputte 456 
et al. showed that faecal microbial richness was decreased in female patients with 457 
faster intestinal transit time measured with Bristol Stool Scale (BBS) as a proxy of 458 
intestinal transit time[57]. Thus, the patients with diarrhoea had the least diverse 459 
faecal microbiota, and different enterotypes existed in patients with different BBS 460 
scores. In loose stool the Prevotella enterotype dominated, while the 461 
Ruminococcaeceae-Bacteroides enterotype, which includes the genus 462 
Methanobrevibacter with the main species M. smithii, dominates in harder stool. 463 
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This supports the repeated findings of M. smithii in AN patients and suggests M. 464 
smithii to be perhaps correlated mainly with transit time, which is frequently 465 
decreased in AN, rather than with AN psychopathology. Interestingly, Archaea 466 
including Methanobrevibacter and M. smithii have been found to be below detection 467 
limit in ileal effluent from ileostomy patients [30] suggesting this specific Archaeon 468 
might dominate mainly in the colorectum and less in the small intestine.  469 
Vandeputte et al. concluded that transit time may be a selective force on microbial 470 
life strategies. In line with this, different transit times within the individual GI tract 471 
may promote growth of different species and offer less diversity in compartments 472 
with faster transit, i.e. the small intestine. In line with this, several studies have found 473 
significant differences in microbiota composition between different compartments in 474 
the GI tract in patients with ileostomy, autopsy patients, and patients undergoing 475 
both gastro-duodenoscopy and colonoscopy [58,30-32], and studies have found 476 
separate clusters of bacteria at both family and species taxonomic levels, when 477 
comparing colonic and rectal mucosal samples with faeces in healthy control 478 
persons and patients with IBS [35,29,33,59,34]. Thus, different microbial 479 
compositions exist within different intestinal compartments and even between 480 
faeces and rectal mucosal samples indicating the importance of intestinal mucosal 481 
biopsies for microbiota analysis in specific compartments. 482 
From an immunological point of view, the small intestine is also an interesting 483 
location as the microbiota is important for immunological homeostasis and 484 
susceptibility to immune-mediated diseases and disorders through the Peyer’s 485 
patches and other parts of the gut-associated-lymphoid-tissue (GALT), which are 486 
prominent in the small intestine and constitute a major line of defence against 487 
pathogens in the GI tract [60,61].  488 
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To retrieve samples from the small intestine, one will need to use pinch or 489 
submucosal biopsy from endoscopy [54], alternatively using more novel 490 
technologies, such as capsule endoscopy, which need further research before 491 
implementation [62].  492 
However, despite the several studies that point at the small intestine as an 493 
immunologically and metabolically important anatomical location for AN, faeces 494 
samples remain the easiest to collect and should continue to be the standard 495 
approach to analyzing the gut microbiota until the use of more minimally invasive 496 
approaches, such as capsule endoscopy, are further developed.  497 
 498 
The mechanistic link between gastrointestinal illnesses and psychiatric disorders 499 
has been well-established[63]. Raevouri et al. found an increased prevalence of 500 
autoimmune disorders in patients with eating disorders, which could possibly be 501 
caused by alterations in the gut microbiota, while another study found that early life 502 
stress altered the microbiota, the systemic immune responses, and resulted in an 503 
elevated HPA-axis function in a rat model [26,64]. It has also been established in a 504 
systematic review that more than 50 % of patients with IBS also meet the criteria for 505 
mood disorders[65]. 506 
The relation between weight gain and clinical symptoms were assessed in two 507 
studies [38,37] and one weight restoration study found that total GI scores 508 
(reflecting complaints) were improved by weight gain, although individual symptoms 509 
did not change [38], while the other weight restoration study described an 510 
association between within-sample alpha diversity and levels of depression, anxiety, 511 
and eating disorder psychopathology in AN at baseline [37]. Borgo et al. also found 512 
a negative correlation between depression and Clostridium spp. (p=0.089) and an 513 
 22 
 
inverse correlation between faecal butyrate concentration and depression 514 
(p=0.0379) and anxiety (p=0.0206) scores in AN patients compared to controls, 515 
while Breton et al. found correlations between ClpB in plasma and several 516 
subscales on the EDI-2 in all eating disorder patients and with MADRS total score 517 
and anhedonia score in AN patients when compared to controls (both p<0.05) [42]. 518 
These findings may support that it is the gut-brain-axis that is underlying, or at least 519 
involved, in these symptoms in AN, and ClpB in plasma potentially provides an 520 
interesting link between the gut and the brain. The gut–brain axis has been 521 
described as a bidirectional communication network that monitors and integrates gut 522 
functions and connects them to cognitive and emotional centres of the brain. This 523 
network includes the central, autonomic, and enteric nervous systems, in addition to 524 
the neuroendocrine, enteroendocrine, and neuroimmune systems [66]. Furthermore, 525 
the network might mediate both the effects of genetic and environmental factors on 526 
brain development and function, and has been proposed to be involved in the 527 
aetiology of several psychiatric disorders [67]. Albeit early findings, which require 528 
validation in repeated and larger studies before any clear conclusions can be made, 529 
they point in a direction for the design of future microbiota studies, which should 530 
include the assessment of psychiatric symptoms in AN over time. 531 
 532 
There were a number of potential weaknesses in all studies included. All studies 533 
included were conducted in adults except the study by Mack et al. and Patient C in 534 
the case series[45], and AN usually has an onset in the adolescence, which may 535 
imply that the results were the effects of long standing undernutrition, and/or a 536 
selected diet, i.e. as caused by mainly external factors and less from any internal 537 
inherent morphological or structural deviation. However, it may also be inherent 538 
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morphological or structural deviations that explain differences between adolescents 539 
and adults with AN, or why the disease has persisted into adulthood. It is also 540 
possible that observed abnormalities in the microbiota in adults with AN are absent 541 
in their adolescent counterparts as a result of different hormonal levels, or it may 542 
relate to other maturational effects. Another limitation of the studies is that all 543 
studies have included females only, neglecting the fact that 10% of AN patients are 544 
males, which make the results hard to extrapolate to a male population with AN, 545 
though limiting the population to females only reduces the risk of sex as a 546 
confounder in the studies.  547 
All of the studies were experimental and albeit several were well designed, the 548 
studies were in general not designed to adjust for potential bias. For the sake of 549 
compliance with the rules of systematic reviews, we included a bias analysis (see 550 
link in methods section to our online protocol). We found that recruitment was 551 
selective e.g. based upon available patients at the ward, and that selection of 552 
healthy controls was biased in some studies e.g. including available staff or family 553 
members of staff. This may imply that the controls used may not reflect changes in a 554 
general/normal population, and using control persons that are genetically related 555 
might underestimate potential findings as the intestinal microbiota might also be 556 
genetically based and certain Bacteria and Archaea might be shared within families. 557 
Furthermore, the choice of timepoint for investigation in the cross-sectional studies 558 
and other factors such as sample collection procedures, calorie intake and contents 559 
of the diet [68], activity level, and medication were not always specified and may 560 
account for variation between studies. In addition, transit time, i.e. stool consistency, 561 
varies from person to person and has been shown to have a significant impact on 562 
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microbial composition [57], and only one study accounted for stool frequency 563 
measured with the Gastro-Questionnaire [69].  564 
In the weight restoration studies, calory intake was only controlled for in the study by 565 
Mack et al., apart from the case series, where calory intake was measured 566 
extensively throughout hospitalization [45]. Additionally, activity level were in general 567 
also not controlled for, which may have influenced bowel movements and energy 568 
expenditure. Furthermore, not all studies examined the abundance of microbiota, 569 
and the duration of weight restoration in the two large longitudinal studies was not 570 
equal [38,37], and in the cross-sectional studies severity and duration of AN were 571 
not consistently specified throughout the studies, why these may have differed 572 
substantially and contributed to differences in the results [40,39,41-43,36]. Only one 573 
individual was studied in the case study [44] and three individuals in the case series 574 
[45] and the relevance on a great scale to the characteristics of the microbiota in AN 575 
and replicability therefore remain limited. 576 
Potential differences in the methods used to determine the microbiota, i.e. 577 
differences in sampling, nucleic acid extraction, and analysis techniques etc. can 578 
also have contributed to the variability in results [54]. 579 
Other limitations were that not all studies examined the abundance and diversity of 580 
microbiota, why a potential link between overall abundance and diversity of 581 
microbiota and AN remain undefined. In addition, different clinical aspects were 582 
investigated in the two large weight restoration studies making their results hard to 583 
compare.   584 
 585 
Conclusion 586 
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Few studies have examined the microbiota in AN, and all studies thus far have been 587 
experimental, and hypothesis generating. Larger, controlled studies will strengthen 588 
the validity of the results and should be a clear recommendation for future studies. 589 
Future studies should focus more on reporting specific microbial species either 590 
through marker gene analysis based on an amplicon of a single gene or through 591 
metagenomic sequencing, which attempts to sequence all or most genes in a 592 
sample. 593 
An issue raised in this systemic review is that faeces samples may not optimally 594 
reflect differences in the microbiome that are biologically relevant for AN as they are 595 
proxies for the microbiome in the intestinal microbiota rather than reflecting true 596 
host-microbe interactions in the various gut compartments. It is proposed that future 597 
studies on the microbiota in AN in addition to faeces samples consider collecting, 598 
when possible, faeces biopsies from the small intestine, where breakdown and 599 
absorption of nutrients occur, and where a large impact of the microbiota on 600 
biological functions, and thereby symptoms and signs, is likely to occur. However, 601 
analyzing the microbiota from faeces samples remains to date the most convenient, 602 
minimally invasive, and easiest obtainable way to analysing the microbiota in AN 603 
and potentially finding a biomarker. The intestinal microbiota in AN is an interesting 604 
field and has yet to be fully unraveled.  605 
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